Related Experiment Videos
Sparing of neuronal function postseizure with gene therapy.
J McLaughlin1, B Roozendaal, T Dumas
1Department of Biological Sciences, Stanford University, Stanford, CA 94305, USA.
Summary
Gene therapy can prevent neuron death but not always preserve function. Glut-1 glucose transporter (GT) gene therapy preserved hippocampal function, unlike Bcl-2, despite similar neuroprotection.
Area of Science:
- Neuroscience
- Gene Therapy
- Cell Death Mechanisms
Background:
- Gene therapy shows promise in protecting neurons from neurological insults.
- Current methods often focus on reducing neurotoxicity without ensuring functional recovery.
Purpose of the Study:
- To investigate whether neuroprotection via gene therapy translates to functional preservation.
- To compare the mechanisms and functional outcomes of two distinct gene therapy approaches.
Main Methods:
- Utilized a herpes simplex virus-1 system to overexpress Glut-1 glucose transporter (GT) or Bcl-2 in hippocampal neurons.
- Assessed neuroprotection and functional preservation following excitotoxic insults in vitro and in vivo.
- Evaluated spatial maze performance as a measure of hippocampal function.
Main Results:
- Both GT and Bcl-2 overexpression reduced hippocampal neuron loss similarly.
- GT overexpression targeted early, energy-dependent cell death pathways and reduced oxygen radicals.
- Bcl-2 overexpression targeted cell death pathways downstream of energetic and oxidative stress.
- Only GT-mediated protection preserved hippocampal function, as evidenced by spatial maze performance.
Conclusions:
- Gene therapeutic sparing of neurons does not automatically equate to sparing of function.
- The mechanism of neuroprotection is critical in determining functional outcomes.
- Targeting cellular energetics, such as with Glut-1 glucose transporter (GT), may be key for preserving neuronal function after injury.